Show
Sort by
-
DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology
-
Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue-induced HBeAg seroconversion
-
- Journal Article
- A1
- open access
Caucasian ethnicity, but not treatment cessation is associated with HBsAg loss following nucleos(t)ide analogue-induced HBeAg seroconversion
-
Belgian experience with direct acting antivirals in people who inject drugs
-
Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results
-
Multicenter Belgian experience of sofosbuvir medical need program in pre- and post liver transplantation patients : safety and efficacy results
-
- Conference Paper
- C3
- open access
Mitochondrial cardiotoxicity of a prototype HCV NS3-protease inhibitor is characterized by a specific electrocardiographic signature in mice
-
The human liver-uPA-SCID mouse. Optimisation and Application for the in vivo study of anti-Hepatitis C Virus strategies.
(2011) -
In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus
-
Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice
-
Experimental models for hepatitis C viral infection
-
Anti-CD81 Antibodies Can Prevent a Hepatitis C Virus Infection In Vivo
-
ANTI-CD81 ANTIBODIES CAN PREVENT A HEPATITIS C VIRUS INFECTION IN VIVO
-
Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain
-
Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse
-
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial
-
Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity
-
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
(2006) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 103(10). p.3805-3809 -
Lopinavir/ritonavir- and indinavir-induced thrombocytopenia in a patient with HIV infection
-
Efavirenz-associated Stevens-Johnson syndrome